Back to BAX Stock Lookup

Baxter Int'l (BAX) – Press Releases

Mar 30, 2015 09:00 AM Baxter Expands Access to Healthcare Through Collaborations and Charitable Giving
Mar 20, 2015 03:46 PM Fitch Maintains Baxter International on Rating Watch Negative
Mar 13, 2015 09:00 AM Baxter BioScience Announces Positive Phase III Results for BAX 817, Investigational Recombinant Treatment for Hemophila A and B Patients with Inhibitors
Mar 9, 2015 07:00 AM CTI BioPharma And Baxter Announce Positive Top-Line Results From Phase 3 Persist-1 Trial Of Pacritinib For Patients With Myelofibrosis
Mar 4, 2015 09:00 AM Baxter’s BioScience Business Acquires Biopharmaceutical Company SuppreMol
Feb 23, 2015 09:00 AM Baxter Selects Bannockburn, Ill., Facility as Location for Baxalta Global Headquarters
Feb 19, 2015 04:15 PM Baxter to Present at Barclay’s Global Healthcare Conference
Feb 17, 2015 09:00 AM Baxter Declares Quarterly Dividend
Feb 12, 2015 04:30 PM Baxter Provides Progress Update on Gene Therapy Program, Including Phase I/II Clinical Trial of BAX 335, Investigational Gene Therapy Treatment for Hemophilia B
Feb 11, 2015 09:00 AM Baxter Presents Additional Data from Pivotal Study of BAX 855, Extended Half-Life Investigational Recombinant FVIII Based on ADVATE for Hemophilia A
Feb 10, 2015 04:15 PM Baxter to Present at Cowen & Company’s 35th Annual Health Care Conference
Jan 29, 2015 07:00 AM Baxter’s Fourth Quarter Financial Results Exceed Expectations
Jan 21, 2015 01:41 AM PharmaEngine Announces Phase 2 PEPCOL Study Presented at the 2015 ASCO GI of PEP02 (MM-398) in Combination with 5-FU/LV in Unresectable Metastatic Colorectal Cancer
Jan 20, 2015 09:00 AM Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous Renal Replacement Therapy
Jan 20, 2015 08:00 AM Merrimack Pharmaceuticals Presents Additional Analyses of Phase 3 MM-398 NAPOLI-1 Study at the American Society of Clinical Oncology (ASCO) 2015 Gastrointestinal Cancers Symposium
Jan 19, 2015 04:00 AM PharmaEngine Announces Expanded Analyses of Phase 3 MM-398 NAPOLI-1 Study Presented at the 2015 ASCO GI Substantiate the Positive Results of MM-398 in Combination with 5-FU/LV
Jan 15, 2015 09:00 AM Palmetto Health in Columbia, South Carolina, Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service

Back to BAX Stock Lookup